IPP Bureau
Sanofi India to demerge healthcare businesses
By IPP Bureau - May 12, 2023
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
Bliss GVS Pharma Q4 FY2023 consolidated PAT drops at Rs. 3.34 Cr
By IPP Bureau - May 12, 2023
The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023
Lilly allocates additional US $50 million to Social Impact Venture Capital portfolio
By IPP Bureau - May 12, 2023
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
By IPP Bureau - May 12, 2023
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Gilead acquires XinThera to strengthen pipeline in oncology
By IPP Bureau - May 12, 2023
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
Takeda pledges support to HAE patients through its ‘Sunrise patient support program’
By IPP Bureau - May 11, 2023
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
AIIA and CCRAS jointly organised session for research and education in Ayush
By IPP Bureau - May 11, 2023
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Orchid Pharma Q4 FY23 consolidated PAT up at Rs. 59.13 Cr
By IPP Bureau - May 11, 2023
The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023
Evonik partners with Safic-Alcan to boost offering of advanced food ingredients
By IPP Bureau - May 11, 2023
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS
By IPP Bureau - May 11, 2023
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
Lupin posts Q4FY23 consolidated PAT up at Rs. 235.96 Cr
By IPP Bureau - May 10, 2023
The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023
Venus Remedies bolsters its position in oncology space with marketing approval from Philippines, Iraq
By IPP Bureau - May 10, 2023
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
Cigniti bags ‘Best IoT Healthcare Platform’ award in 2023
By IPP Bureau - May 10, 2023
The Awards recognizes standout digital health & medical technology products and companies
Boehringer Ingelheim begins clinical development for fibrotic diseases
By IPP Bureau - May 10, 2023
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Zion Pharma inks agreement with Roche to develop and commercialize brain-penetrable compounds
By IPP Bureau - May 10, 2023
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
